A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma

Cancer

Volumn 95, Issue 7, 2002, Pages 1451-1456

  Potters, Louis ^a   Purrazzella, Rosemary ^b   Brustein, Sheryl ^b   Fearn, Paul ^a   Leibel, Steven A ^a   Kattan, Michael W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Mercy Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BRACHYTHERAPY; CARCINOMA; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0036785398     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10869     Document Type: Article

References (19)

1. Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst. 1998;90:766-771.
2. Potters L, Cha C, Oshinsky G, Venkatraman E, Zelefsky M, Leibel S. Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy [in process citation]. Cancer J Sci Am. 1999;5:301-306.
3. Kattan MW, Zelefsky MJ, Kupelian PA, Scardino PT, Fuks Z, Leibel SA. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol. 2000;18:3352-3359.
4. D'Amico AV, Schultz D, Silver B, et al. The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2001;49:679-684.
5. Fleming I, Cooper JS, Henson DE, et al. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven, 1997.
6. Nag S, Bice WS, DeWyngaert JK, Prestidge BR, Stock R, Yu Y. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys. 2000;46:221-230.
7. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys. 1997;37:1035-1041.
8. Kattan MW, Fearn PA, Leibel S, Potters L. The definition of biochemical failure in patients treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys. 2000;48:1469-1474.
9. Lee ET. Statistical methods for survival data analysis. New York: John Wiley and Sons, 1992.
10. Harrell FE, Lee KL, Califf RM, Prycr DB, Rosati RA. Regression modeling strategies for improved prognostic prediction. Stat Med. 1984;3:143-152.
11. Efron B, Tibshirani RJ. An introduction to bootstrapping. 1st ed. New York: Chapman and Hall, 1993.
12. Harrell FE, Lee KL, Mark DB. Multivariate prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
13. Kattan MW, Zelefsky M, Kupelian P, Scardino PT, Fuks Z, Leibel S. A pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol. 2000;18:3352-3359.
14. Kattan MW, Potters L, Blasko JC, et al. Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. Urology. 2001;58:393-399.
15. D'Amico AV, Whittington R, Malkowicz SB, et al. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol. 1999;17:168-172.
16. Shipley WU, Thames HD, Sandler HM, et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA. 1999;281:1598-1604.
17. Miles BJ, Giesler RB, Kattan MW. Recall and attitudes in patients with prostate cancer. Urology. 1999;53:169-174.
18. Ross PL, Scardino PT, Kattan MW. A catalog of prostate cancer nomograms. J Urol. 2001;165:1562-1568.
19. Clark JA, Wray NP, Ashton CM. Living with treatment decisions: regrets and quality of life among men treated for prostate cancer. J Clin Oncol. 2001;19:72-80.